The global immunohematology market was valued at $1.9 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
Immunohematology, also known as blood banking or transfusion medicine, is a specialized branch of laboratory medicine that focuses on the study of blood groups and antibodies associated with blood transfusion. It involves the identification and characterization of blood group antigens on the surface of red blood cells and the corresponding antibodies present in plasma. The main goal of immunohematology is to ensure safe and compatible blood transfusions by matching the blood type of the donor with that of the recipient to prevent adverse reactions. This field plays a crucial role in transfusion therapy, organ transplantation, and managing various hematologic disorders.
The growth of the global immunohematology market is driven by rise in the prevalence of chronic diseases and surge in the number of surgical procedures, which have significantly boosted the need for accurate blood typing and cross-matching, which are crucial for safe transfusion practices. In addition, aging population has led to a higher incidence of conditions such as anemia and leukemia, further escalating the demand for immunohematology products. Moreover, rise in awareness and stringent regulations regarding blood safety and donor compatibility are contributing to the expansion of immunohematology market growth.
However, high cost associated with advanced immunohematology instruments and reagents, which can limit their adoption, especially in developing regions with limited healthcare budgets. On the other hand, adoption of automated and digital blood testing platforms offers significant potential for improving diagnostic accuracy and efficiency, catering to the growing demand for rapid and reliable blood typing and cross-matching. For instance, in May 2023, Bio-Rad Laboratories, Inc. announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. The IH-500 NEXT System is used with Bio-Rad's ID-Cards, offering a broad portfolio for both routine testing (type and screen) and specialized testing, including single antigen determination and newborn screening.
Segmentation Overview
The global immunohematology market is segmented into product, application, end user, and region. Depending on the product, the market is categorized into analyzers & systems and reagents. By application, it is classified into blood-related diseases, HIV, and others. According to end user, the market is divided into hospitals, diagnostic Laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the reagents segment held the highest share in the market in 2023.
Depending on the application, the blood-related diseases segment accounted for the maximum market share in 2023.
According to end user, the hospitals segment was the largest shareholder in 2023.
Region wise, North America dominated the global immunohematology market in 2023.
Competitive Scenario
The major players operating in the immunohematology market include Bio-Rad Laboratories, Inc, Werfen, Grifols, S.A., Danaher Corporation, Siemens, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, and Cardinal Health. These players have adopted several tactics such as product advancement & diversification, mergers & acquisitions, partnerships, collaborations, and advertising to strengthen their position in the competitive environment.
Immunohematology, also known as blood banking or transfusion medicine, is a specialized branch of laboratory medicine that focuses on the study of blood groups and antibodies associated with blood transfusion. It involves the identification and characterization of blood group antigens on the surface of red blood cells and the corresponding antibodies present in plasma. The main goal of immunohematology is to ensure safe and compatible blood transfusions by matching the blood type of the donor with that of the recipient to prevent adverse reactions. This field plays a crucial role in transfusion therapy, organ transplantation, and managing various hematologic disorders.
The growth of the global immunohematology market is driven by rise in the prevalence of chronic diseases and surge in the number of surgical procedures, which have significantly boosted the need for accurate blood typing and cross-matching, which are crucial for safe transfusion practices. In addition, aging population has led to a higher incidence of conditions such as anemia and leukemia, further escalating the demand for immunohematology products. Moreover, rise in awareness and stringent regulations regarding blood safety and donor compatibility are contributing to the expansion of immunohematology market growth.
However, high cost associated with advanced immunohematology instruments and reagents, which can limit their adoption, especially in developing regions with limited healthcare budgets. On the other hand, adoption of automated and digital blood testing platforms offers significant potential for improving diagnostic accuracy and efficiency, catering to the growing demand for rapid and reliable blood typing and cross-matching. For instance, in May 2023, Bio-Rad Laboratories, Inc. announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. The IH-500 NEXT System is used with Bio-Rad's ID-Cards, offering a broad portfolio for both routine testing (type and screen) and specialized testing, including single antigen determination and newborn screening.
Segmentation Overview
The global immunohematology market is segmented into product, application, end user, and region. Depending on the product, the market is categorized into analyzers & systems and reagents. By application, it is classified into blood-related diseases, HIV, and others. According to end user, the market is divided into hospitals, diagnostic Laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the reagents segment held the highest share in the market in 2023.
Depending on the application, the blood-related diseases segment accounted for the maximum market share in 2023.
According to end user, the hospitals segment was the largest shareholder in 2023.
Region wise, North America dominated the global immunohematology market in 2023.
Competitive Scenario
The major players operating in the immunohematology market include Bio-Rad Laboratories, Inc, Werfen, Grifols, S.A., Danaher Corporation, Siemens, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, and Cardinal Health. These players have adopted several tactics such as product advancement & diversification, mergers & acquisitions, partnerships, collaborations, and advertising to strengthen their position in the competitive environment.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Analyzers and Systems
- Reagents
By Application
- Blood-related Diseases
- HIV
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Bio-Rad Laboratories, Inc
- Werfen
- Grifols, S.A.
- Danaher Corporation
- Siemens
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Cardinal Health
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: IMMUNOHEMATOLOGY MARKET, BY PRODUCT
CHAPTER 5: IMMUNOHEMATOLOGY MARKET, BY APPLICATION
CHAPTER 6: IMMUNOHEMATOLOGY MARKET, BY END USER
CHAPTER 7: IMMUNOHEMATOLOGY MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Key Market Players in the Immunohematology Market include:- Bio-Rad Laboratories, Inc
- Werfen
- Grifols, S.A.
- Danaher Corporation
- Siemens
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Cardinal Health
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 233 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 1.9 billion |
| Forecasted Market Value ( USD | $ 3 billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
